Skip to main content
رجوع
ELVN logo

Enliven Therapeutics, Inc.

جودة البيانات: 100%
ELVN
NASDAQ Healthcare Biotechnology
KWD 30.81
▲ KWD 1.78 (6.13%)
القيمة السوقية: 1.84B
نطاق اليوم
KWD 28.96 KWD 31.36
نطاق 52 أسبوعًا
KWD 13.30 KWD 31.76
حجم التداول
874,656
متوسط 50 يوم / 200 يوم
KWD 27.54 / KWD 21.92
الإغلاق السابق
KWD 29.03

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Healthcare (626 نظير)

المقياس السهم وسيط القطاع
P/E -17.8 0.4
P/B 4.0 2.9
ROE % -27.0 3.7
Net Margin % 3.8
Rev Growth 5Y % 10.0
D/E 0.0 0.2

النقاط الرئيسية

Debt/Equity of 0.00 — conservative balance sheet
Negative free cash flow of -70.46M

النمو

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
-26.95%
ROIC-19.51%
Net MarginN/A
Op. MarginN/A

الأمان

Debt / Equity
0.00
Current Ratio28.66
Interest Coverage0.00

التقييم

P/E Ratio
-17.77
P/B Ratio4.01
EV/EBITDAN/A
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 0.0 Net Income (TTM) -103.69M
ROE -26.95% ROA -21.78%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -70.46M
ROIC -19.51% FCF Growth (3Y) N/A
Safety
Debt / Equity 0.00 Current Ratio 28.66
Interest Coverage 0.00 Dividend Yield 0.00%
Valuation
P/E Ratio -17.77 P/B Ratio 4.01
P/S Ratio N/A PEG Ratio 2.65
EV/EBITDA N/A Dividend Yield 0.00%
Market Cap 1.84B Enterprise Value 1.74B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 0.0 0.0 0.0 0.0 0.0
Net Income -103.69M -89.02M -71.58M -37.66M -24.74M
EPS (Diluted) -1.83 -1.89 -2.01 -6.03 -3.17
Gross Profit -263,000.0 0.0 0.0 0.0 0.0
Operating Income -119.66M -104.55M -83.53M -38.79M -24.76M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 476.17M 325.76M 271.87M 83.30M 113.33M
Total Liabilities 16.68M 15.92M 25.96M 160.12M 6.47M
Shareholders' Equity 459.60M 309.85M 245.91M -76.83M 106.86M
Total Debt 399,000.0 0.0 335,000.0 323,000.0 159,000.0
Cash & Equivalents 98.90M 124.12M 100.14M 75.54M 110.02M
Current Assets 474.88M 318.13M 266.15M 77.75M 110.67M
Current Liabilities 16.57M 15.92M 25.89M 9.72M 5.75M